San Diego-centered Viking Therapeutics marked alone as a serious competitor inside the weight loss drug marketplace in February after revealing promising info from the mid-stage trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when offered as being a weekly injection As well as in March the com